Actively Recruiting
Prevalence of NAFLD in T1DM Patients
Led by Ziekenhuis Oost-Limburg · Updated on 2025-07-28
138
Participants Needed
1
Research Sites
156 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To determine the prevalence of NAFLD in T1DM patients.
CONDITIONS
Official Title
Prevalence of NAFLD in T1DM Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with type 1 diabetes mellitus (T1DM)
- 18 years of age or older
- Written informed consent obtained
You will not qualify if you...
- Excessive alcohol use
- Other causes of liver disease or secondary causes of liver steatosis
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Ziekenhuis Oost-Limburg
Genk, Limburg, Belgium, 3600
Actively Recruiting
Research Team
L
Leen Heyens, MsC
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here